This channel is the one directly affected by the Category 1/Category 2 decision
The path from bench to bedside is often complex and fraught with regulatory, safety, and efficacy concerns
New York Citys health insurer stopped covering GLP-1 drugs for city employees in 2025 while Bostons leaders are considering limiting such coverage for city employees because of an insurance rate hike largely driven by the GLP-1 drug cost
Its a slower, more supportive approach that works best when used consistently
ABT-263 (navitoclax), a pan-inhibitor of BCL-2 family proteins, suppresses tumor metastasis and recurrence by eliminating chemotherapy-induced senescent cancer cells and hepatocytes within the tumor microenvironment
Samples were then combined and co-precipitated by the addition of 9 volumes of methanol:chloroform (4:1.5), vortexed and centrifuged at 12,000 g for 15 min